Skip to main content
CLX
NYSE Industrial Applications And Services

Clorox FY26 10-K: Debt Surges to $5.1B After GOJO Deal; EPS Falls 26% Amid CEO Exit

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Household Product Stocks · Consumer
Sentiment info
Negative
Importance info
8
Price
$105.2
Mkt Cap
$12.715B
52W Low
$84.7
52W High
$128.9
52W Position info
24% above low
Off High info
18% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

CLX sits 24% above its 52-week low of $84.7.

Summary

Clorox's FY26 10-K reveals debt doubling to $5.1B after the GOJO acquisition, a 26% drop in EPS, and a CEO succession underway — a pivotal moment for the consumer products giant.


Key Events · Earnings and Guidance · CLX

  • Debt Surges to $5.1 Billion

    Total debt climbed from $2.5 billion to $5.1 billion, largely to fund the $2.15 billion GOJO acquisition and the $476 million Glad joint venture buyout. In February 2026, S&P downgraded Clorox's long-term credit rating to BBB from BBB+.

  • Earnings Decline Sharply

    Net sales fell 5% to $6.72 billion, and diluted EPS dropped 26% to $4.81, driven by lower shipments following an ERP transition pull-forward and higher manufacturing and logistics costs.

  • CEO Resignation Announced

    Chair and CEO Linda Rendle announced her planned resignation for health reasons. The board has initiated a search for a successor, creating leadership uncertainty during a period of high leverage and integration risk.

  • GOJO Acquisition Closed

    On April 1, 2026, Clorox completed the $2.15 billion acquisition of GOJO Industries (Purell), expanding into health and hygiene. Integration risks and $717 million in goodwill are now on the balance sheet.


Analysis · CLX · Industrial Applications And Services

The annual report paints a picture of a company under considerable financial strain. Debt has more than doubled to $5.1 billion, driven by the $2.15 billion GOJO acquisition and the $476 million Glad buyout, which pushed leverage higher and triggered a credit rating downgrade. Earnings fell sharply, with diluted EPS down 26% on lower sales and higher costs. Adding to the uncertainty, the CEO's planned resignation creates a leadership vacuum. While investment-grade ratings and debt covenant compliance remain intact, the heavy debt load, declining profitability, and CEO transition present a challenging outlook.

At the time of this filing, CLX was trading at $105.20 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $12.7B. The 52-week trading range was $84.70 to $128.90. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CLX - Latest Insights

CLX
Aug 03, 2026, 7:42 PM EDT
Source: Binance News
Importance Score:
7
Price at Filing: $98.63
Real-time Price: $105.20 info
Change: +$6.57 (+7%) info
Market Cap: $12.715B info
CLX
Aug 03, 2026, 5:52 PM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $98.71
Real-time Price: $105.20 info
Change: +$6.49 (+7%) info
Market Cap: $12.715B info
CLX
Aug 03, 2026, 4:12 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $99.36
Real-time Price: $105.20 info
Change: +$5.84 (+6%) info
Market Cap: $12.715B info
CLX
Aug 03, 2026, 4:10 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $99.17
Real-time Price: $105.20 info
Change: +$6.03 (+6%) info
Market Cap: $12.715B info
CLX
Jun 17, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $95.10
Real-time Price: $105.20 info
Change: +$10.10 (+11%) info
Market Cap: $12.715B info